If you've ever looked into gut microbiome testing, you've probably encountered two main technologies: 16S rRNA gene sequencing and shotgun metagenomics. Both promise to reveal what's living in your gut, but they go about it very differently—and those differences matter for what you can learn.
Choosing the right test isn't just about cost (though that's a factor). It's about matching the method to your goals. A new study comparing both approaches head-to-head in over 150 human stool samples provides some of the clearest evidence yet about where each technique shines—and where it falls short [1].
Key takeaways
- 16S sequencing is cheaper and sufficient for general wellness insights, while shotgun metagenomics provides species-level and functional data for deeper analysis.
- Head-to-head research shows 16S captures only part of the gut community that shotgun reveals, with lower alpha diversity estimates [1].
- Shotgun is preferred when you need functional insights (like metabolic capacity) or species-level precision for specific health conditions.
- Both methods correlate reasonably well for broad diversity patterns but can differ substantially at lower taxonomic ranks.
- Choose your test based on your goal: routine monitoring suits 16S; precision health assessments may warrant shotgun.
What 16S Sequencing Actually Does
16S rRNA gene sequencing is the workhorse of microbiome research. It targets a single gene—the 16S rRNA gene—that exists in all bacteria but not in humans. By reading this genetic marker, scientists can identify which bacterial families, genera, and sometimes species are present in a sample.
The method is relatively affordable and works well for answering questions like: What types of bacteria dominate my gut? or How does my microbiome compare to a healthy reference? It's become the standard for large population studies because it balances cost with meaningful taxonomic information [4].
However, 16S has a key limitation: it only captures a snapshot of taxonomic identity, not what those microbes are actually doing. You learn who's there, but not what genes they're carrying.
Enter Shotgun Metagenomics
Shotgun metagenomics takes a broader approach. Instead of targeting one gene, it sequences all DNA in a sample—bacterial, viral, fungal, and even human. This gives researchers a much fuller picture, including:
- Species-level identification (not just genus or family)
- Functional gene content—what metabolic pathways are present
- Strain-level variation that 16S often misses
Studies using both methods have shown that shotgun reveals microbial diversity that 16S simply cannot detect [1]. In the 2024 BMC Genomics study comparing both methods in 156 stool samples, shotgun identified substantially more of the gut community than 16S alone.
What the Head-to-Head Research Shows
The most direct evidence comes from Bars-Cortina et al. (2024), who sequenced the same 156 stool samples using both 16S and shotgun [1]. Their findings reveal important trade-offs:
- Depth of detection: 16S captured only part of the gut community that shotgun revealed. Some genera were detected only by 16S, showing each method has unique strengths.
- Abundance differences: When looking at shared taxa, abundance was positively correlated between methods—but at lower taxonomic ranks (species, genus), they often disagreed significantly.
- Diversity measures: Alpha diversity (within-sample variety) was consistently lower in 16S data compared to shotgun. Beta diversity (between-sample differences) showed moderate correlation between the two platforms.
- Prediction power: Machine learning models trained on shotgun data sometimes showed predictive power in independent test sets, while 16S models were less consistent [1].
When 16S Makes Sense
Despite its limitations, 16S remains valuable for many scenarios:
- Budget-conscious testing: 16S is significantly cheaper, making it accessible for routine monitoring or large studies [3].
- Standardized comparisons: Because 16S has been used for over a decade, there's massive public data for comparison—including reference databases for conditions like obesity [4] and pediatric health.
- Clinical screening: For general wellness assessments where genus-level information suffices, 16S provides actionable insights at a lower price point.
Research in oral microbiomes similarly found that while metagenomics offers greater taxonomic and functional detail, 16S remains essential when cost or bioinformatics complexity are constraints [11].
When Shotgun Is Worth the Investment
Shotgun metagenomics earns its place when you need deeper answers:
- Functional insights: If you want to know about metabolic capacity—say, SCFA production potential or bile acid metabolism—shotgun delivers gene-level data [2].
- Precision medicine: For conditions like colorectal cancer risk, where specific microbial signatures matter, shotgun's species-level resolution can be critical [1].
- Mechanistic research: When studying how microbes influence outcomes like immunotherapy response or neurological health, functional data from shotgun helps uncover the 'why' behind associations [2][5].
The trade-off is cost and complexity. Shotgun requires more computational resources and expertise to analyze, which translates to higher prices for consumers.
The Bottom Line: Matching Method to Goal
There's no universal 'best' method—only the right tool for your question. Here's a simple framework:
- Choose 16S for: general wellness checks, trend monitoring over time, budget-conscious screening, population-level research.
- Choose shotgun for: detailed functional profiling, mechanistic research, precision health assessments, cases where species-level identification matters.
As microbiome science matures, some labs now offer both in a tiered approach—starting with 16S and offering shotgun as an upgrade. The key is understanding what each number in your report actually means [1][10].
Frequently asked questions
Is 16S sequencing accurate enough for health insights?
Yes—16S reliably identifies bacteria at genus and family levels and correlates well with shotgun for broad diversity patterns. However, it underestimates rare taxa and may miss species-level differences that matter for specific conditions [1].
Why is shotgun metagenomics more expensive?
Shotgun sequences all DNA in a sample rather than a single gene, generating far more data. This requires more computational processing, larger databases, and greater expertise—all of which increase cost [11].
Can 16S detect harmful bacteria?
16S can identify many pathogenic genera and families, but may miss specific disease-causing strains that require species or strain-level resolution—which shotgun provides [1].
Which method do researchers prefer for studies?
Both are widely used. 16S dominates large population studies due to lower cost; shotgun is preferred for mechanistic research where functional gene data is needed [3][4].
Will my results be comparable over time if I switch methods?
Not directly. Studies show moderate correlation between methods for diversity metrics, but abundance values differ significantly. For longitudinal tracking, sticking with one platform is recommended [1].
References
- Comparison between 16S rRNA and shotgun sequencing in colorectal cancer, advanced colorectal lesions, and healthy human gut microbiota — Bars-Cortina D et al., 2024, BMC genomics
- Gut microbial bile and amino acid metabolism associate with peanut oral immunotherapy failure — Özçam M et al., 2025, Nature communications
- Standardization of gut microbiome analysis in sports — Mancin L et al., 2024, Cell reports. Medicine
- Gut Microbiota and Short-Chain Fatty Acids: Key Factors in Pediatric Obesity and Therapeutic Targets — Pînzariu AC et al., 2025, International journal of molecular sciences
- Gut Microbiota and Neurovascular Patterns in Amnestic Mild Cognitive Impairment — Kazen AB et al., 2025, Brain sciences
- Best practices framework for using 16S rRNA gene sequencing in poultry microbiota research — Lyte JM et al., 2026, Poultry science
- Metabolic modeling reveals determinants of prebiotic and probiotic treatment efficacy across multiple human intervention trials — Quinn-Bohmann N et al., 2026, PLoS biology
- STROBE-causal machine learning for the human microbiome: systematic review on methodological innovations and validation frameworks — Khelfaoui I et al., 2026, Frontiers in microbiology
- Soil microbiome perturbation impedes growth of Bouteloua curtipendula and increases relative abundance of soil microbial pathogens — Hobbs A et al., 2026, PloS one
- Choosing Between Short-Read 16S, Full-Length ONT 16S, and Long-Read Shotgun Metagenomics for Soil Microbiome Studies: A Critical Review of the Benchmarking Evidence — Albastaki A et al., 2026, Microorganisms
- Assessing the Oral Microbiome in Women of Reproductive Age: A Narrative Review — Ionaș TH et al., 2025, Clinics and practice
- The gut microbiome in colorectal anastomotic leakage: from mechanisms to precision — Sun S et al., 2026, Frontiers in medicine
- Divergent pathways of mango fractions in promoting metabolic health: from gut microbiota remodeling to direct systemic regulation — Cai S et al., 2026, Frontiers in nutrition
- Fecal microbiota transplantation from psychiatric patients to mice - systematic review of methodologies and a call for standardization — D'Onofrio AM et al., 2026, Translational psychiatry
- Across the Social Network of the Gut: Bacterial, Fungal, and Viral Determinants of Checkpoint Inhibitor Efficacy and Toxicity — Antohi AL et al., 2026, International journal of molecular sciences
- Precision Microbial Therapeutics for Infertility: Next-Generation Probiotics, Engineered Biologics and Translational Pathways — Li L et al., 2026, Microbial biotechnology